Follow
Anna Ludovica FRACANZANI
Anna Ludovica FRACANZANI
Department of Pathophysiology and Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore
Verified email at unimi.it
Title
Cited by
Cited by
Year
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
19822020
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
11362019
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ...
Hepatology 48 (3), 792-798, 2008
8962008
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7942021
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
7082010
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
5912015
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ...
Gastroenterology 122 (2), 274-280, 2002
4392002
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target
P Dongiovanni, AL Fracanzani, S Fargion, L Valenti
Journal of hepatology 55 (4), 920-932, 2011
4142011
Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association
S Fargion, A Piperno, MD Cappellini, M Sampietro, AL Fracanzani, ...
Hepatology 16 (6), 1322-1326, 1992
3971992
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ...
Official journal of the American College of Gastroenterology| ACG 102 (6 …, 2007
3542007
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ...
Gastroenterology 138 (3), 905-912, 2010
3412010
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis
S Fargion, M Mattioli, AL Fracanzani, M Sampietro, D Tavazzi, P Fociani, ...
Official journal of the American College of Gastroenterology| ACG 96 (8 …, 2001
3272001
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease
AL Fracanzani, D Conte, M Fraquelli, E Taioli, M Mattioli, A Losco, ...
Hepatology 33 (3), 647-651, 2001
3212001
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
AL Fracanzani, L Burdick, S Raselli, P Pedotti, L Grigore, G Santorelli, ...
The American journal of medicine 121 (1), 72-78, 2008
3142008
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
3022011
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ...
Journal of hepatology 74 (4), 775-782, 2021
2652021
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ...
Scientific reports 7 (1), 4492, 2017
2642017
Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development
M Borzio, S Fargion, F Borzio, AL Fracanzani, AM Croce, T Stroffolini, ...
Journal of hepatology 39 (2), 208-214, 2003
2642003
Nonalcoholic fatty liver disease and vascular disease: state-of-the-art
S Fargion, M Porzio, AL Fracanzani
World journal of gastroenterology: WJG 20 (37), 13306, 2014
2542014
NASH in lean individuals
R Younes, E Bugianesi
Seminars in liver disease 39 (01), 086-095, 2019
2532019
The system can't perform the operation now. Try again later.
Articles 1–20